SANTA CLARA, Calif., April 10, 2019 /PRNewswire/ — Every year, across the United States (US), close to 50 percent of patients fail to understand treatment plans and care management guidelines, and approximately 20 percent of them switch providers due to a lack of trust in their care teams. Next-generation patients prefer having access to personalized clinical information on the go, requiring caregivers to coordinate medical insight across the care continuum more efficiently than ever. Almost 70 percent of patients reported feeling fully satisfied when they received coordinated care from a provider-designated team that appears confident in identifying the right intervention strategies and delivering episodic medical support compassionately. However, such services cannot be scaled without the contribution of progressive digital health solutions. As a result, the care coordination software market is poised to witness significant traction from payers, hospitals and physician practices across the US. This is expected to drive the $1.55 billion care coordination software market toward $3.18 billion by 2022 at a compound annual growth rate of 15.4 percent.
“The care coordination software market is embracing large-scale innovation, aided by advanced technologies such as AI and blockchain, which support data interoperability and normalization within a defined clinical network,” said Koustav Chatterjee, Industry Analyst, Transformational Health. “The growing need to auto-trigger worklists and personalize intervention plans for complex patient populations will further drive investments in care coordination IT (CCIT).”
Frost & Sullivan’s recent analysis, US Care Coordination Software Market, Forecast to 2023, examines the adoption drivers across a variety of settings. It also presents the challenges impacting the market and the outlook for the adoption of care coordination software among three key customer segments. It presents forecasts for the overall market growth over a six-year period and opportunities within the total market.
For further information on this analysis, please visit: http://frost.ly/3ck.
“While regulatory hurdles had hindered the adoption of CCIT in the past, the latest US policies advocating the Promoting Interoperability initiative by Centers of Medicare and Medicaid Services (CMS), the cross-continuum interoperability, are expected to accelerate the adoption of both software and service solutions,” noted Chatterjee. “Business models will remain largely centered on transitional care management, and chronic condition management is highly regulated under various value-based reimbursement programs. Legacy electronic health record (EHR) platforms, which allow third-party integration with CCIT to remain interoperable in the front end, will thrive. Collaboration with traditional ICT vendors such as Microsoft, Apple, and Salesforce is also expected by both payers and providers.”
For additional growth opportunities, CCIT vendors are likely to:
US Care Coordination Software Market, Forecast to 2023 is part of Frost & Sullivan’s global Digital Health Growth Partnership Service program.
About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
US Care Coordination Software Market, Forecast to 2023
9AB9-48
Contact:
Mariana Fernandez
Corporate Communications
T: +1 210 348 10 12
T: +54 11 4778 3540
E: Mariana.Fernandez@frost.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/ai-powered-care-coordination-software-gives-vendors-competitive-edge-in-the-era-of-personalized-healthcare-300829893.html
SOURCE Frost & Sullivan
HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…
This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…
Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…
MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…